Purchase Order 75N91023P00588
Award Date 8/1/23
Potential Completion Date 7/31/24
Potential Value $22K
Federal Agency
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
North Bethesda, MD 20852, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. on September 17, 2020, for one Agilent Seahorse XFE96 analyzer (64-bit) valued at $203,939.10, with completion targeted for September 24, 2020. Performance occurs in Marshallton, Delaware. The order was issued under firm fixed price terms with no set-aside designation, following a special notice solicitation posted August 6, 2020, with a due date of August 14, 2020.</p>
- Agilent Technologies Inc., through its Customer Service and Sales Division, has been awarded a purchase order by the National Cancer Institute of the National Institutes of Health within the Department of Health and Human Services. Valued at fourteen thousand two hundred seventy-one dollars, this firm fixed price contract is for the repair of a Seahorse Cell Analyzer located in Bethesda, Maryland and will be performed over the course of one year beginning in November 2023. No subcontractors or...
- The National Cancer Institute (NCI), a civilian federal agency, awarded a $22,831.20 firm fixed price purchase order to Agilent Technologies Inc. for a service agreement to provide the Seahorse XFE96 Analyzer. This equipment is used for cellular bioenergetics research and will be delivered by July 31, 2025. Agilent, a global leader in life sciences instrumentation, has a long history of providing analytical equipment and services to various federal agencies through both prime and subcontracts....
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Agilent Technologies Inc. Customer Service And Sales Division for the maintenance of a SEAHORSE XFE96 ANALYZER (S/N 411017) located in Bethesda, Maryland. The total potential value of the contract is $17,982.00 and the period of performance concludes on December 4, 2020. Agilent Technologies Inc. is a global...
- This firm fixed price purchase order was awarded by the Department of Health and Human Services National Institutes of Health Clinical Center to Agilent Technologies Inc. Customer Service And Sales Division for maintenance services supporting the Seahorse XFe96 Analyzer used by the Center for Cellular Engineering. Valued at $21,740.40, this one-year contract provides maintenance agreement coverage for the analyzer equipment from December 2023 through December 2024 to support patient care testing...
- This contract was awarded by the Department of Health and Human Services, National Institutes of Health, National Cancer Institute to Agilent Technologies Inc. to procure an Agilent Seahorse XFe96 Analyzer, a specialized instrument for measuring cellular metabolism. The contract has a firm fixed price of $164,253.00 and does not have a set-aside designation. The Agilent Seahorse XFe96 Analyzer will be used to support research activities at the National Cancer Institute. Agilent Technologies Inc....
- This firm fixed price purchase order for $108,702 was awarded by the Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke to Agilent Technologies Inc. for a preventative maintenance and service agreement for an Agilent Technologies Seahorse XFe96 Analyzer (serial number 410250). The agreement is for a one year base period of performance from February 2023 through February 2028 and includes four one-year option periods. No...
- <p>The National Cancer Institute issued a purchase order to Agilent Technologies Inc. on July 26, 2026, for Seahorse Analyzer maintenance agreement services with a ceiling value of $19,929.78 and a completion date of July 25, 2027. Performance occurs in Bethesda, Maryland. The order is firm fixed price with no set-aside category.</p>
- The Department of Health and Human Services National Institutes of Health National Institute of Environmental Health Sciences awarded a firm fixed price purchase order to Agilent Technologies Inc. Customer Service And Sales Division to provide an AGILENT SEAHORSE XFE96 ANALYZER. The award, which did not have a set-aside designation, had a potential value of $149,781.75 and a completion date of August 22, 2017. Agilent Technologies Inc. is a global leader in life sciences, diagnostics, and...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $21,036 purchase order to Agilent Technologies Inc. Customer Service And Sales Division for service of the RTCA Xcelligence machine. As the parent company, Agilent Technologies, Inc. Agilent Laboratory Division will perform the work doing business as Agilent Labs. The period of performance is one year, from December 15, 2023 through December 14, 2024. The contract has a firm fixed...